Jay R. Wiggins

430 total citations
21 papers, 330 citations indexed

About

Jay R. Wiggins is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Jay R. Wiggins has authored 21 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Jay R. Wiggins's work include Cardiac electrophysiology and arrhythmias (5 papers), Cardiac pacing and defibrillation studies (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Jay R. Wiggins is often cited by papers focused on Cardiac electrophysiology and arrhythmias (5 papers), Cardiac pacing and defibrillation studies (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). Jay R. Wiggins collaborates with scholars based in United States, Germany and United Kingdom. Jay R. Wiggins's co-authors include Paul Erhardt, William C. Lumma, Elinor H. Cantor, David Pang, M. Sullivan, Hannah M. Linden, Brenda F. Kurland, Arthur L. Bassett, Chaitanya Divgi and W. R. Ingebretsen and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Jay R. Wiggins

20 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay R. Wiggins United States 10 134 101 64 55 34 21 330
M. Evans United Kingdom 11 57 0.4× 109 1.1× 31 0.5× 67 1.2× 89 2.6× 13 353
W.C. Eckelman United States 12 58 0.4× 174 1.7× 193 3.0× 26 0.5× 57 1.7× 24 429
Herbert Birnböck Germany 8 80 0.6× 71 0.7× 24 0.4× 25 0.5× 79 2.3× 12 238
Robert H. Seevers United States 8 131 1.0× 71 0.7× 143 2.2× 8 0.1× 18 0.5× 16 371
Stephen B. Haber United States 11 151 1.1× 85 0.8× 262 4.1× 67 1.2× 49 1.4× 15 484
Shuichi Mori Japan 14 111 0.8× 240 2.4× 45 0.7× 51 0.9× 22 0.6× 33 442
Vamsidhar Akurathi United States 7 88 0.7× 236 2.3× 68 1.1× 17 0.3× 37 1.1× 14 398
Lutz F. Schweiger United Kingdom 12 75 0.6× 111 1.1× 173 2.7× 32 0.6× 77 2.3× 21 436
Donald B. Miller United States 15 241 1.8× 131 1.3× 38 0.6× 32 0.6× 13 0.4× 33 598
Heike Radeke United States 10 96 0.7× 84 0.8× 321 5.0× 92 1.7× 15 0.4× 14 517

Countries citing papers authored by Jay R. Wiggins

Since Specialization
Citations

This map shows the geographic impact of Jay R. Wiggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay R. Wiggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay R. Wiggins more than expected).

Fields of papers citing papers by Jay R. Wiggins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay R. Wiggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay R. Wiggins. The network helps show where Jay R. Wiggins may publish in the future.

Co-authorship network of co-authors of Jay R. Wiggins

This figure shows the co-authorship network connecting the top 25 collaborators of Jay R. Wiggins. A scholar is included among the top collaborators of Jay R. Wiggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay R. Wiggins. Jay R. Wiggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schlief, Reinhard, et al.. (2002). Safety of the Galactose–Based Ultrasound Contrast Agent Levovist. Academic Radiology. 9(1). S240–S242. 12 indexed citations
3.
Wiggins, Jay R., et al.. (1998). Safety of Levovist injection in patients undergoing exercise stress echocardiography: A placebo-controlled study. Academic Radiology. 5. S192–S194. 7 indexed citations
4.
Wiggins, Jay R., et al.. (1994). New Clinical Trial Experience with Iopromide. Investigative Radiology. 29. S208–S210. 9 indexed citations
5.
Shaw, Kenneth J., et al.. (1992). Cardiotonic agents. 7. Prodrug derivatives of 4-ethyl-1,3-dihydro-5-[4-(2-methyl-1H-imidazol-1-yl)benzoyl]-2H-imidazol-2-one. Journal of Medicinal Chemistry. 35(7). 1267–1272. 17 indexed citations
6.
Lampe, John W., Paul Erhardt, William C. Lumma, et al.. (1990). Cardiotonic agents. 6. Histamine analogs as potential cardiovascular selective H2 agonists. Journal of Medicinal Chemistry. 33(6). 1688–1697. 6 indexed citations
7.
Erhardt, Paul, et al.. (1989). Cardiotonic agents. 5. Fragments from the heterocycle-phenyl-imidazole pharmacophore. Journal of Medicinal Chemistry. 32(6). 1173–1176. 21 indexed citations
8.
Owens, Albert H., R. Richard Goehring, John W. Lampe, et al.. (1988). Cardiotonic agents 4. Dimaprit analogues as potential cardiovascular selective H2-agonists. European Journal of Medicinal Chemistry. 23(3). 295–300. 7 indexed citations
9.
Pang, David, et al.. (1988). Tissue specificity of cAMP‐phosphodiesterase inhibitors: Rolipram, amrinone, milrinone, enoximone, piroximone, and imazodan. Drug Development Research. 14(2). 141–149. 9 indexed citations
10.
Erhardt, Paul, William C. Lumma, Jay R. Wiggins, et al.. (1987). Cardiotonic agents. 1. Novel 8-aryl substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents. Journal of Medicinal Chemistry. 30(8). 1337–1342. 98 indexed citations
11.
Goehring, R. Richard, William C. Lumma, Paul Erhardt, et al.. (1987). β-Methylsulfonylamino phenethylamines and aryloxypropylamines as potential β-adrenergic agents. European Journal of Medicinal Chemistry. 22(2). 165–167. 1 indexed citations
12.
Wiggins, Jay R., et al.. (1984). Implications of Altered Inotropic Effects of Phenylephrine in Pressure-Overloaded Cat Ventricular Muscle. Journal of Cardiovascular Pharmacology. 6(2). 238–243. 1 indexed citations
13.
Wiggins, Jay R., et al.. (1983). Amrinone Relaxes Potassium-Induced Contracture of Failing Right Ventricular Muscle of Cats. Journal of Cardiovascular Pharmacology. 5(2). 335–340. 11 indexed citations
14.
Bergey, James L., et al.. (1981). Oximes: ‘Enzymatic’ slow channel antagonists in canine cardiac purkinje fibers?. European Journal of Pharmacology. 71(2-3). 307–319. 22 indexed citations
15.
Wiggins, Jay R., Henry Gelband, & Arthur L. Bassett. (1979). Depressant effects of phenoxybenzamine on potassium contracture in cat ventricular muscle. European Journal of Pharmacology. 59(1-2). 111–114. 2 indexed citations
16.
Wiggins, Jay R. & Sherman Bloom. (1979). Paradoxical Actions of Quinidine in Hyperpermeable Heart Cells. Journal of Cardiovascular Pharmacology. 1(1). 69–76. 2 indexed citations
17.
Wiggins, Jay R. & Paul F. Cranefield. (1974). Effect on Membrane Potential and Electrical Activity of Adding Sodium to Sodium-Depleted Cardiac Purkinje Fibers. The Journal of General Physiology. 64(4). 473–493. 12 indexed citations
18.
Bassett, Arthur L., Jay R. Wiggins, Peter Danilo, Kristina Nilsson, & Henry Gelband. (1974). DIRECT AND INDIRECT INOTROPIC EFFECTS OF NICOTINE ON CAT VENTRICULAR MUSCLE. Journal of Pharmacology and Experimental Therapeutics. 188(1). 148–156. 10 indexed citations
19.
Wiggins, Jay R., Peter Danilo, Henry Gelband, & Arthur L. Bassett. (1973). NICOTINE AND POTASSIUM CHLORIDE CONTRACTURE IN MAMMALIAN VENTRICLE. Journal of Pharmacology and Experimental Therapeutics. 185(3). 457–467. 7 indexed citations
20.
Wiggins, Jay R., et al.. (1970). Effect of imidazole on bone 45Ca release in white-throated sparrow, Zonotrichia albicollis. Comparative Biochemistry and Physiology. 34(2). 297–300. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Evans Breakdown of academic impact, for papers by W.C. Eckelman Breakdown of academic impact, for papers by Herbert Birnböck Breakdown of academic impact, for papers by Robert H. Seevers Breakdown of academic impact, for papers by Stephen B. Haber Breakdown of academic impact, for papers by Shuichi Mori Breakdown of academic impact, for papers by Vamsidhar Akurathi Breakdown of academic impact, for papers by Lutz F. Schweiger Breakdown of academic impact, for papers by Donald B. Miller Breakdown of academic impact, for papers by Heike Radeke
Rankless by CCL
2026